+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Molecular Imaging System Market - Global Forecast 2026-2032- Product Image
Clinical Molecular Imaging System Market - Global Forecast 2026-2032- Product Image
Sale

Clinical Molecular Imaging System Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122469
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Molecular Imaging System Market is projected to reach USD 2.36 Billion in 2026. It is expected to continue growing at a CAGR of 5.64%, reaching USD 3.32 Billion by 2032.

Clinical Molecular Imaging Systems: Executive Summary

Clinical molecular imaging systems support the visualization of biological processes for diagnosis, treatment planning, therapy monitoring, and research translation. The field spans modalities and integrated workflows that connect image acquisition with radiopharmaceutical use, quantitative analysis, clinical interpretation, and data management. Adoption is shaped by diagnostic value, reimbursement, regulatory requirements, infrastructure readiness, specialist expertise, and the availability of appropriate tracers.

Workflow Integration Is Reshaping Clinical Molecular Imaging

The landscape is shifting from standalone imaging equipment toward coordinated diagnostic pathways. Hospitals and imaging providers increasingly evaluate systems according to workflow efficiency, interoperability, quantitative consistency, patient throughput, radiation-safety procedures, and compatibility with multidisciplinary care. Hybrid imaging, standardized protocols, remote collaboration, and more specialized applications are encouraging closer alignment among nuclear medicine, radiology, oncology, cardiology, neurology, and pathology teams.

Artificial Intelligence Strengthens Quantification and Clinical Decision Support

Artificial intelligence is contributing to image reconstruction, denoising, segmentation, lesion detection, motion correction, workflow prioritization, and quantitative biomarker extraction. Its cumulative impact depends on the quality and representativeness of training data, validation across scanners and sites, explainability, cybersecurity, and regulatory oversight. AI is most useful when integrated into established clinical workflows with human review, rather than treated as a substitute for specialist judgment.

Regional Priorities Reflect Uneven Infrastructure and Access

North America emphasizes advanced oncology, neurology, cardiology, integrated data platforms, and evidence-based workflow optimization. Europe combines strong clinical research capabilities with detailed regulatory, privacy, and radiation-protection requirements. Asia-Pacific shows varied adoption, with sophisticated centers alongside infrastructure and workforce gaps; Japan, China, South Korea, Australia, and India each present distinct pathways. Latin America is influenced by uneven access to equipment, tracer supply, reimbursement, and specialist training. The Middle East is developing centralized advanced-care capacity, while Africa’s progress is closely tied to workforce development, dependable supply chains, public investment, and regional referral networks.

International Groups Reveal Distinct Policy and Adoption Contexts

ASEAN markets face differing levels of infrastructure maturity, cross-border supply-chain complexity, and specialist availability, making training and interoperable referral pathways important. BRICS members combine large and diverse healthcare systems with varied regulatory and reimbursement environments, creating opportunities for scalable protocols and locally appropriate service models. The European Union prioritizes harmonized safety, privacy, evidence, and device requirements. G7 systems generally emphasize clinical validation, quality assurance, and advanced research translation. GCC countries are investing in specialized healthcare capacity and centralized expertise, while NATO members show diverse health-system structures but share interest in resilience, secure data exchange, and continuity of critical medical services.

Country-Level Adoption Depends on Health-System Readiness

Australia combines advanced tertiary care with geographic access challenges. Brazil and Mexico must address regional disparities, reimbursement, and infrastructure distribution. Canada’s large geography makes coordinated referral and service networks important. China is expanding advanced clinical capacity while navigating regulatory, procurement, and regional variation. France, Germany, Italy, Spain, and the United Kingdom emphasize specialized care, evidence generation, and public-system integration within distinct national frameworks. India faces substantial variation between major centers and underserved areas, alongside strong demand for scalable diagnostic pathways. Japan and South Korea have sophisticated technology ecosystems and aging-population needs. Russia’s environment is shaped by domestic capability, infrastructure variation, and supply-chain considerations. The United States places strong emphasis on specialized oncology and precision-medicine workflows, reimbursement evidence, and regulatory compliance.

Prioritize Interoperability, Evidence, and Workforce Capability

Industry leaders should design systems around complete clinical workflows rather than isolated hardware performance. Priorities include open interoperability, robust cybersecurity, transparent AI validation, standardized quantitative protocols, radiation-safety controls, and service models that reduce downtime. Organizations should build evidence with representative patient populations, engage clinicians and patients early, and align development with reimbursement and regulatory requirements. Partnerships with hospitals, tracer producers, academic centers, and training institutions can strengthen implementation, while tiered deployment models can extend access across facilities with different levels of expertise.

Methodology: Triangulating Clinical, Technology, and Policy Evidence

This executive summary uses a structured qualitative assessment of the clinical molecular imaging system landscape. The approach considers modality and workflow development, clinical use cases, AI integration, infrastructure, regulation, reimbursement, workforce requirements, interoperability, and regional access conditions. Insights are organized across the required regions, international groups, and countries, with emphasis on recurring evidence-based drivers and constraints. No market estimates, market shares, forecasts, or company-specific claims are used.

Clinical Value Will Depend on Integrated, Trusted Deployment

Clinical molecular imaging systems are advancing toward more quantitative, connected, and biologically informative care. Sustainable progress will depend less on equipment acquisition alone and more on validated clinical utility, reliable tracer and service ecosystems, skilled personnel, secure data practices, and equitable access. Leaders that combine technical performance with workflow integration, evidence generation, and responsible AI governance will be better positioned to translate molecular imaging capabilities into consistent patient benefit.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Clinical Molecular Imaging System Market, by Product Type
7.1. Introduction
7.2. Hybrid Pet/Ct Systems
7.3. Pet Systems
7.3.1. Three D Pet
7.3.2. Two D Pet
7.4. Pet/Mri Systems
7.5. Spect Systems
7.5.1. Dual Head
7.5.2. Multi Head
7.5.3. Single Head
8. Clinical Molecular Imaging System Market, by Technology
8.1. Introduction
8.2. Photomultiplier Tubes
8.3. Scintillation Detectors
8.3.1. Bismuth Germanate
8.3.2. Lutetium Oxyorthosilicate
8.4. Solid State Detectors
8.4.1. Cadmium Zinc Telluride
8.4.2. Silicon Photomultipliers
9. Clinical Molecular Imaging System Market, by Application
9.1. Introduction
9.2. Cardiology
9.2.1. Myocardial Perfusion Imaging
9.2.2. Viability Studies
9.3. Infectious Diseases
9.4. Neurology
9.4.1. Alzheimer’s Disease
9.4.2. Epilepsy
9.4.3. Parkinson’s Disease
9.5. Oncology
9.5.1. Breast Cancer
9.5.2. Lung Cancer
9.5.3. Prostate Cancer
10. Clinical Molecular Imaging System Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Diagnostic Centers
10.3.1. Chain Diagnostic Centers
10.3.2. Independent Diagnostic Centers
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Research Institutes
10.5.1. Academic Institutes
10.5.2. Government Institutes
11. Clinical Molecular Imaging System Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Clinical Molecular Imaging System Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Clinical Molecular Imaging System Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Analogic Corporation
15.2. Aspect Imaging Ltd.
15.3. Bioscan, Inc.
15.4. Bruker Corporation
15.5. Canon Medical Systems Corporation
15.6. Carestream Health, Inc.
15.7. CMR Naviscan Corporation
15.8. Cubresa Inc.
15.9. Esaote S.p.A.
15.10. Fujifilm Holdings Corporation
15.11. GE Healthcare
15.12. Hitachi, Ltd.
15.13. Hologic, Inc.
15.14. Koninklijke Philips N.V.
15.15. Mediso Ltd.
15.16. MILabs B.V.
15.17. Mindray Bio-Medical Electronics Co., Ltd.
15.18. PerkinElmer, Inc.
15.19. PicoTools GmbH
15.20. Samsung Medison Co., Ltd.
15.21. Shimadzu Corporation
15.22. Siemens Healthineers AG
15.23. Thermo Fisher Scientific Inc.
15.24. Trivitron Healthcare
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Clinical Molecular Imaging System Market, Years Considered for the Study
FIGURE 2. Global Clinical Molecular Imaging System Market, Research Design
FIGURE 3. Global Clinical Molecular Imaging System Market, Research Framework
FIGURE 4. Global Clinical Molecular Imaging System Market, Data Triangulation
FIGURE 5. Global Clinical Molecular Imaging System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Clinical Molecular Imaging System Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Clinical Molecular Imaging System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Clinical Molecular Imaging System Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Clinical Molecular Imaging System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Clinical Molecular Imaging System Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Clinical Molecular Imaging System Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Clinical Molecular Imaging System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Clinical Molecular Imaging System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Clinical Molecular Imaging System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Clinical Molecular Imaging System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Clinical Molecular Imaging System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Clinical Molecular Imaging System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Clinical Molecular Imaging System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Clinical Molecular Imaging System Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Clinical Molecular Imaging System Market Segmentation & Coverage
TABLE 2. Global Clinical Molecular Imaging System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Hybrid Pet/Ct Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Hybrid Pet/Ct Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Hybrid Pet/Ct Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Pet Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Pet Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Pet Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Three D Pet Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Three D Pet Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Three D Pet Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Two D Pet Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Two D Pet Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Two D Pet Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Pet/Mri Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Pet/Mri Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Pet/Mri Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Spect Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Spect Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Spect Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Dual Head Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Dual Head Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Dual Head Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Multi Head Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Multi Head Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Multi Head Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Single Head Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Single Head Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Single Head Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 32. Global Photomultiplier Tubes Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Photomultiplier Tubes Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Photomultiplier Tubes Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Scintillation Detectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Scintillation Detectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Scintillation Detectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Bismuth Germanate Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Bismuth Germanate Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Bismuth Germanate Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Lutetium Oxyorthosilicate Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Lutetium Oxyorthosilicate Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Lutetium Oxyorthosilicate Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Solid State Detectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Solid State Detectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Solid State Detectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Cadmium Zinc Telluride Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Cadmium Zinc Telluride Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Cadmium Zinc Telluride Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Silicon Photomultipliers Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Silicon Photomultipliers Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Silicon Photomultipliers Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 54. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Myocardial Perfusion Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Myocardial Perfusion Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Myocardial Perfusion Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Viability Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Viability Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Viability Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Alzheimer’s Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Alzheimer’s Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Alzheimer’s Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Epilepsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Epilepsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Epilepsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Parkinson’s Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Parkinson’s Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Parkinson’s Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Prostate Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Prostate Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Prostate Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Chain Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Chain Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Chain Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Independent Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Independent Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Independent Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Government Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Government Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Government Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Clinical Molecular Imaging System Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Clinical Molecular Imaging System Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 137. North America Clinical Molecular Imaging System Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. North America Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 139. North America Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 140. North America Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 141. North America Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 142. North America Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 143. North America Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 144. North America Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. North America Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 146. North America Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 147. North America Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 148. North America Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. North America Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 150. North America Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 151. North America Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 152. Latin America Clinical Molecular Imaging System Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Latin America Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. Latin America Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 155. Latin America Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 156. Latin America Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 157. Latin America Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 158. Latin America Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 159. Latin America Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Latin America Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 161. Latin America Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 162. Latin America Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 163. Latin America Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Latin America Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 165. Latin America Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 166. Latin America Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 167. Europe Clinical Molecular Imaging System Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Europe Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. Europe Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 170. Europe Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 171. Europe Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 172. Europe Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 173. Europe Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 174. Europe Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Europe Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 176. Europe Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 177. Europe Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 178. Europe Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Europe Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 180. Europe Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 181. Europe Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 182. Middle East Clinical Molecular Imaging System Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Middle East Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. Middle East Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 185. Middle East Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 186. Middle East Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 187. Middle East Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 188. Middle East Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 189. Middle East Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Middle East Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 191. Middle East Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 192. Middle East Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 193. Middle East Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Middle East Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 195. Middle East Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 196. Middle East Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 197. Africa Clinical Molecular Imaging System Market Size, by Region, 2017-2032 (USD Million)
TABLE 198. Africa Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. Africa Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 200. Africa Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 201. Africa Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 202. Africa Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 203. Africa Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 204. Africa Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Africa Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 206. Africa Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 207. Africa Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 208. Africa Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Africa Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 210. Africa Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 211. Africa Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 212. Global Clinical Molecular Imaging System Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. ASEAN Clinical Molecular Imaging System Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. ASEAN Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 215. ASEAN Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 216. ASEAN Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 217. ASEAN Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. ASEAN Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 219. ASEAN Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 220. ASEAN Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. ASEAN Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 222. ASEAN Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 223. ASEAN Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 224. ASEAN Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. ASEAN Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 226. ASEAN Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 227. ASEAN Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 228. GCC Clinical Molecular Imaging System Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. GCC Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. GCC Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 231. GCC Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 232. GCC Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 233. GCC Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 234. GCC Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 235. GCC Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. GCC Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 237. GCC Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 238. GCC Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 239. GCC Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. GCC Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 241. GCC Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 242. GCC Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 243. European Union Clinical Molecular Imaging System Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. European Union Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. European Union Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 246. European Union Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 247. European Union Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 248. European Union Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 249. European Union Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 250. European Union Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. European Union Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 252. European Union Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 253. European Union Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 254. European Union Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. European Union Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 256. European Union Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 257. European Union Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 258. BRICS Clinical Molecular Imaging System Market Size, by Group, 2017-2032 (USD Million)
TABLE 259. BRICS Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 260. BRICS Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 261. BRICS Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 262. BRICS Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 263. BRICS Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 264. BRICS Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 265. BRICS Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. BRICS Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 267. BRICS Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 268. BRICS Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 269. BRICS Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. BRICS Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 271. BRICS Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 272. BRICS Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 273. G7 Clinical Molecular Imaging System Market Size, by Group, 2017-2032 (USD Million)
TABLE 274. G7 Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 275. G7 Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 276. G7 Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 277. G7 Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 278. G7 Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 279. G7 Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 280. G7 Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. G7 Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 282. G7 Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 283. G7 Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 284. G7 Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. G7 Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 286. G7 Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 287. G7 Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 288. NATO Clinical Molecular Imaging System Market Size, by Group, 2017-2032 (USD Million)
TABLE 289. NATO Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 290. NATO Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 291. NATO Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 292. NATO Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 293. NATO Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 294. NATO Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 295. NATO Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 296. NATO Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 297. NATO Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 298. NATO Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 299. NATO Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. NATO Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 301. NATO Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 302. NATO Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 303. Global Clinical Molecular Imaging System Market Size, by Country, 2017-2032 (USD Million)
TABLE 304. United States Clinical Molecular Imaging System Market Size, 2017-2032 (USD Million)
TABLE 305. United States Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 306. United States Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 307. United States Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 308. United States Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 309. United States Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 310. United States Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 311. United States Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 312. United States Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 313. United States Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 314. United States Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 315. United States Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. United States Clinical Molecular Imaging System Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
TABLE 317. United States Clinical Molecular Imaging System Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 318. United States Clinical Molecular Imaging System Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 319. Canada Clinical Molecular Imaging System Market Size, 2017-2032 (USD Million)
TABLE 320. Canada Clinical Molecular Imaging System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 321. Canada Clinical Molecular Imaging System Market Size, by Pet Systems, 2017-2032 (USD Million)
TABLE 322. Canada Clinical Molecular Imaging System Market Size, by Spect Systems, 2017-2032 (USD Million)
TABLE 323. Canada Clinical Molecular Imaging System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 324. Canada Clinical Molecular Imaging System Market Size, by Scintillation Detectors, 2017-2032 (USD Million)
TABLE 325. Canada Clinical Molecular Imaging System Market Size, by Solid State Detectors, 2017-2032 (USD Million)
TABLE 326. Canada Clinical Molecular Imaging System Market Size, by Application, 2017-2032 (USD Million)
TABLE 327. Canada Clinical Molecular Imaging System Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 328. Canada Clinical Molecular Imaging System Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 329. Canada Clinical Molecular Imaging System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 330. Canada Clinical Molecular Imaging System Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. Canada Clinical Molecular I

Companies Mentioned

  • Analogic Corporation
  • Aspect Imaging Ltd.
  • Bioscan, Inc.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • CMR Naviscan Corporation
  • Cubresa Inc.
  • Esaote S.p.A.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Mediso Ltd.
  • MILabs B.V.
  • Mindray Bio-Medical Electronics Co., Ltd.
  • PerkinElmer, Inc.
  • PicoTools GmbH
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare

Related Topics

Related Reports

Molecular Imaging CRO Market - Global Forecast 2026-2032 - Product Image

Molecular Imaging CRO Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Molecular Imaging Market Report by Modality, Application, End Use, Countries and Companies Analysis 2026-2034 - Product Image

Molecular Imaging Market Report by Modality, Application, End Use, Countries and Companies Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From
Molecular Imaging System Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Molecular Imaging System Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 91 Pages
  • Global
From
Molecular Imaging - Global Strategic Business Report - Product Image

Molecular Imaging - Global Strategic Business Report

  • Report
  • 392 Pages
  • Global
From
Molecular Imaging Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Molecular Imaging Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.